Strategi Transfer Pricing pada Perusahaan Multinasional

Latar Belakang:
Klien kami, perusahaan farmasi multinasional, menghadapi tantangan besar terkait regulasi transfer pricing di Indonesia.

Tantangan:
Dokumentasi transfer pricing belum sesuai dengan standar OECD dan peraturan perpajakan Indonesia, sehingga berisiko koreksi pajak hingga ratusan miliar rupiah.

Solusi:

• Penyusunan Master File, Local File, dan Country by Country Reporting (CbCR).
• Benchmarking harga transfer sesuai arm’s length principle.
• Simulasi risiko koreksi untuk mitigasi lebih awal.

Hasil Nyata:
Koreksi pajak berhasil ditekan, perusahaan lebih siap menghadapi pemeriksaan transfer pricing.

Mengapa Klien Memilih Kami:
Kami menguasai regulasi internasional dan praktik lokal, memberi strategi yang aman sekaligus efisien.

CTA:
Jangan biarkan transfer pricing jadi risiko tersembunyi. Hubungi kami untuk pendampingan menyeluruh.

Background:
Our client, a multinational pharmaceutical company, faces significant challenges regarding transfer pricing regulations in Indonesia.

Challenge:
Transfer pricing documentation does not yet comply with OECD standards and Indonesian tax regulations, resulting in the risk of tax corrections amounting to hundreds of billions of rupiah.

Solution:

• Preparation of Master Files, Local Files, and Country by Country Reporting (CbCR).
• Benchmarking transfer prices according to the arm's length principle.
• Correction risk simulation for early mitigation.

Real Results:
Tax corrections were successfully reduced, companies were better prepared to face transfer pricing audits.

Why Clients Choose Us:
We master international regulations and local practices, providing strategies that are both safe and efficient.